tradingkey.logo

BioNexus Gene Lab Corp

BGLC
View Detailed Chart
2.110USD
+0.120+6.03%
Close 02/06, 16:00ETQuotes delayed by 15 min
3.79MMarket Cap
LossP/E TTM

BioNexus Gene Lab Corp

2.110
+0.120+6.03%
Intraday
1m
30m
1h
D
W
M
D

Today

+6.03%

5 Days

-18.75%

1 Month

-47.38%

6 Months

-62.72%

Year to Date

-46.58%

1 Year

-45.19%

View Detailed Chart

Key Insights

BioNexus Gene Lab Corp's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 204 out of 392 in the Biotechnology & Medical Research industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

BioNexus Gene Lab Corp's Score

Industry at a Glance

Industry Ranking
204 / 392
Overall Ranking
398 / 4521
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

BioNexus Gene Lab Corp Highlights

StrengthsRisks
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Growing
The company is in a growing phase, with the latest annual income totaling USD 9.51M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 9.51M.
Overvalued
The company’s latest PE is -1.65, at a high 3-year percentile range.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.96.

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

BioNexus Gene Lab Corp News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

BioNexus Gene Lab Corp Info

BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Ticker SymbolBGLC
CompanyBioNexus Gene Lab Corp
CEOTan (Lee Su-Leng)
Websitehttps://www.bionexusgenelab.com/
KeyAI